How Lipfendra, Inclisiran, and New Guidelines Are Changing Cholesterol Management
New cholesterol-lowering therapies like Lipfendra and Inclisiran are reshaping cardiovascular care through updated clinical guidelines.
9 trends tracked about this subject — the full history, oldest to newest below.
New cholesterol-lowering therapies like Lipfendra and Inclisiran are reshaping cardiovascular care through updated clinical guidelines.
Health experts are questioning if current protein intake levels are sufficient for healthy aging, sparking a trend toward increased dietary protein.
New scientific modeling suggests the theoretical upper limit of the human lifespan may extend far beyond previously established biological boundaries.
Conflicting reports emerge over whether creatine supplements inhibit cancer growth or potentially accelerate tumor metastasis.
New research suggests that just 12 weeks of intermittent fasting may help individuals sustain weight loss a full year after the diet ends.
New analysis suggests that weight loss achieved through obesity drugs does not necessarily translate into improved mental health or better job prospects.
Recent coverage highlights new research and expert recommendations regarding dietary changes aimed at lowering stroke risk.
A new study links anti‑inflammatory foods to up to 29% lower dementia risk, even for those with family history or early biomarkers.
New research suggests that Omega-3 DHA supplements may not actually reduce the risk of Alzheimer's disease or improve memory and cognition.